Covid vaccine: Major new trial starts in UK

Covid vaccine: Major new trial starts in UK A major trial of a vaccine to protect against Covid-19 has launched in the UK - the third such trial in the country.

The jab - designed by the Belgian company Janssen - uses a genetically modified common cold virus to train the immune system.

It comes a week after preliminary results showed another vaccine offered 90% protection. BBC News

See also:

• Covid-19: Next two weeks 'crucial' for ending lockdown BBC News
• 'Covid-19: Normal life back next winter, says vaccine creator BBC News
• Coronavirus: Safety officials had 'political' pressure' to approve PPE BBC News
• Covid: Children more likely to be infected in second wave BBC News
• Coronavirus: Patients face long waits for hospital ops in England BBC News
• Covid: Care home visitors to trial regular testing BBC News
• Covid-19: Labour calls for law to stop anti-vaccination fake news online BBC News
• Why does COVID-19 kill some people and spare others? The Daily Mail
• Schools are to blame for more than a thousand outbreaks of coronavirus since September The Daily Mail
• Coronavirus: PPE 'is STILL being denied to some NHS workers' despite huge stockpiles The Daily Mail
• Don’t put key workers at end of the Covid vaccine queue, warn UK unions The Guardian
• Covid vaccines in the UK: who is in charge, and what is the plan? The Guardian
• NHS needs extra £4bn next year because of Covid, Rishi Sunak told The Guardian
• England's test and trace system hit by 'huge' IT problems last month The Guardian
• Better, smarter, local response systems are the only way to avoid further lockdowns The Guardian
• ‘A long and difficult slog’: Chris Whitty predicts hardest winter for NHS in recent memory The Independent
• Specialist ‘long Covid’ clinics to be launched across England The Independent
• Covid UK deaths up by 462 over 24 hours The Independent
• COVID-19: Boris Johnson self-isolating after meeting with MP who tested positive for coronavirus Sky News